Results 101 to 110 of about 4,155 (132)

Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson's Disease. [PDF]

open access: yesNeurotherapeutics, 2022
Kim J   +11 more
europepmc   +1 more source

Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming. [PDF]

open access: yesProc Natl Acad Sci U S A
Yang Y   +16 more
europepmc   +1 more source

Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson's Disease. [PDF]

open access: yesNeurotherapeutics, 2022
Kim J   +11 more
europepmc   +1 more source

Nuclear receptor Rev-erbα role in fine-tuning erythropoietin gene expression. [PDF]

open access: yesBlood Adv
Kumar S   +11 more
europepmc   +1 more source

IL-6 deletion decreased REV-ERBα protein and influenced autophagy and mitochondrial markers in the skeletal muscle after acute exercise. [PDF]

open access: yesFront Immunol, 2022
Pinto AP   +14 more
europepmc   +1 more source

Presenilin 2 N141I mutation induces hyperactive immune response through the epigenetic repression of REV-ERBα. [PDF]

open access: yesNat Commun, 2022
Nam H   +12 more
europepmc   +1 more source

The role of circadian rhythm proteins Rev-Erbα and β in the development of neuronal injury after traumatic brain injury. [PDF]

open access: yesTurk J Med Sci
Pençe ME   +7 more
europepmc   +1 more source

REV-ERBα negatively regulates NLRP6 transcription and reduces the severity of Salmonella infection in mice. [PDF]

open access: yesHeliyon
Sun L   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy